Patents by Inventor Carsten Spanka

Carsten Spanka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CXCR2 inhibitors
    Publication number: 20100069407
    Abstract: The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.
    Type: Application
    Filed: November 21, 2007
    Publication date: March 18, 2010
    Inventors: Neil John Press, David Porter, Carsten Spanka
  • Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
    Patent number: 7625950
    Abstract: Compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, X, Y and n are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: December 1, 2009
    Assignee: Novartis AG
    Inventors: Klaus Hinterding, Carsten Spanka, Frédéric Zecri
  • NOVEL BI-ARYL AMINES
    Publication number: 20090286827
    Abstract: The present invention relates to novel bi-aryl amines of formula (I) and to pharmaceutically acceptable prodrugs, salts, solvates, hydrates, and N-oxides thereof and to pharmaceutical compositions comprising them, methods of their use, and methods of their preparation.
    Type: Application
    Filed: April 2, 2007
    Publication date: November 19, 2009
    Inventors: Ralf Glatthar, David Carcache, Carsten Spanka, Ivan-toma Vranesic, Thomas J. Troxler
  • Amino-propanol derivatives
    Patent number: 7612238
    Abstract: Compounds of formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: November 3, 2009
    Assignee: Novartis AG
    Inventors: Peter Buehlmayer, Klaus Hinterding, Carsten Spanka, Frédéric Zecri
  • 3-METHYL-IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVES
    Publication number: 20090264406
    Abstract: The invention relates to compounds of formula (I) and salts thereof wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).
    Type: Application
    Filed: March 2, 2009
    Publication date: October 22, 2009
    Inventors: Pascal Furet, Clive McCarthy, Joseph Schoepfer, Carsten Spanka, Melanie Stang, Frederic Stauffer
  • Compounds and Compositions as Protein Kinase Inhibitors
    Publication number: 20090137804
    Abstract: The invention relates to compounds of formula (I) wherein the substituents X1, R1, R2, R3 and R4 have the meaning as set forth and explained in the description of the invention, to processes for the preparation of these compounds, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, and a method for the treatment of such a disease.
    Type: Application
    Filed: June 23, 2005
    Publication date: May 28, 2009
    Inventors: Qiang Ding, Nathanael Schiander Gray, Bing Li, Yi Liu, Taebo Sim, Tetsuo Uno, Guobao Zhang, Carole Pissot Soldermann, Werner Breitenstein, Guido Bold, Giorgio Caravatti, Pascal Furet, Vito Guagnano, Marc Lang, Paul W. Manley, Joseph Schoepfer, Carsten Spanka
  • Organic Compounds
    Publication number: 20090005363
    Abstract: The present invention relates to novel nicotinic acid derivatives, of formula (I) wherein the substituents are defined in the specification, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them.
    Type: Application
    Filed: December 18, 2006
    Publication date: January 1, 2009
    Inventors: Ralf Glatthar, David Orain, Carsten Spanka
  • Organic Compounds
    Publication number: 20080242698
    Abstract: The invention relates to novel diamines of the formula in which all variables are as defined in the specification, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
    Type: Application
    Filed: August 29, 2006
    Publication date: October 2, 2008
    Inventors: Peter Josef Flor, Andreas Marzinzik, Joachim Nozulak, Silvio Ofner, Bernard Lucien Roy, Carsten Spanka
  • Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
    Publication number: 20060211658
    Abstract: Compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, X, Y and n are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Application
    Filed: April 29, 2004
    Publication date: September 21, 2006
    Inventors: Klaus Hinterding, Carsten Spanka, Frederic Zecri
  • Amino-propanol derivatives
    Publication number: 20060166940
    Abstract: Compounds of formula I wherein R1, R2, R3, R4 and R5 are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Application
    Filed: September 12, 2003
    Publication date: July 27, 2006
    Inventors: Peter Buehlmayer, Klaus Hinterding, Carsten Spanka, Frederic Zecri